J&J cell Therapy deal falls apart, leaving patients and employees in the lurch.
Fate Therapeutics started 2023 with a massive restart of its business. After ending its partnership
Emily’s Entourage welcomes world-renowned researcher Margarida D. Amaral to the Scientific Advisory Board!
Dr. Margarida D. Amaral, Principal Investigator (PI) on the Faculty of Sciences of the University
The New Way to Live Disease-Free: Getting Rid of Old Cells
James Kirkland began his career in 1982 as a geriatrician, treating aging patients. But he
FDA Approval Puts Ferring Pharma’s Gene Therapy on the Fast Track for Bladder Cancer Treatment
Bladder cancer can be treated with several types of drugs. Gene therapy is now part
Brain Implant Breakthrough: Bezos and Gates Invest In Synchron
Synchron announced earlier this year that it had implanted its brain-computer interface in the first
Novozymes and Chr. Hansen to Create “Bioscience Powerhouse” in New Merger Deal.
Biotechnology companies, Novozymes and Chr. Hansen agreed to bring together the largest ever merger of
FDA approves Ferring Pharmaceuticals first microbiome drug.
On Wednesday, the Food and Drug Administration approved the first treatment that uses bacteria taken from
Biocon kicks off new era with acquisition of Viatris’ biosimilars business.
Biocon Biologics announced on Tuesday that it has successfully completed the acquisition of its partner
FDA approves world’s most expensive drug that costs $3.5 million.
The US Food and Drug Administration (FDA) recently approved a new drug, Hemgenix, for use